Journal Awards

 

Journal Awards

Recognising scientific excellence in publishing and also other indicators of your paper's success; attention, influence & impact

ICB and CTI Publication of the Year Awards

Purpose:

To reward the best original research article published in Immunology & Cell Biology or Clinical & Translational Immunology in that year with an ASI member as first author.

Eligibility:

  • All ASI members who are the first author on any Original articles, Outstanding Observation articles, Theoretical articles or Short Communications published in ICB or CTI
  • Awardee must have been a financial member of ASI in the year in which the paper was published
  • Co-authored articles are eligible for consideration.  If an awarded article is co-authored by a non-member, the award is granted solely to the member author.

Application procedure:

None required.  Recipients are selected by the Editors-in-Chief of Immunology & Cell Biology and Clinical & Translational Immunology.

Assessment Criteria:

  • Scientific excellence, originality and clarity of presentation of the paper, as judged by a panel comprising the Editors-in-Chief of Immunology & Cell Biology and Clinical & Translational Immunology, and ASI President (current and past), Council or their nominees.

Value:

Immunology & Cell Biology Chris and Bhama Parish Publication of the Year Award:

  • AUD $1,000 - sponsored by Wiley
  • Guaranteed speaking slot at the ASI Annual Scientific Meeting 
  • Free registration (Ordinary or Student; at the Early Bird Rate) to the ASI Annual Scientific Meeting.

Clinical & Translational Immunology Publication of the Year Award

  • AUD $1000 - sponsored by Wiley
  • Guaranteed speaking slot at the ASI Annual Scientific Meeting
  • Free registration (Ordinary or Student; at the Early Bird Rate) to the ASI Annual Scientific Meeting.
  • Free video summary for the awardee to share via social media, in presentations or online biographies - sponsored by Wiley

ICB and CTI Social Impact Awards

Another fantastic reason to submit to ICB and CTI- new in 2018

Purpose:

To reward a publication in either Immunology & Cell Biology or Clinical & Translational Immunology with the highest Altmetric Attention Score.  This seeks to recognise other indicators of your paper’s success; the attention, influence, and impact, and is awarded to the corresponding author.

Eligibility:

  • All eligible articles by ASI members and non-members.
  • Eligible articles must be from a category that undergoes peer-review (e.g. original article, review).

Application procedure:

None required.  All eligible articles are automatically considered.
For your best chance to win; tweet, write press releases, engage the media and tell your friends and colleagues to share.

Assessment Criteria:

  • Highest Altmetric Attention Score gained by either an ICB or CTI article. For more on Altmetrics, please click here.

Value:

AUD $500 per award for Immunology & Cell Biology or Clinical & Translational Immunology.

Terms and Conditions:

  1. There is one prize each for articles published in ICB and CTI per year beginning 1 July.
  2. The inaugural prize will be awarded for articles published from 1 July 2018 to 30 June 2019.
  3. The articles must be from a category that undergoes peer-review (e.g. original article, review).
  4. ‘Published’ is defined as having a DOI.
  5. All eligible articles will be automatically considered, including those by non ASI members
  6. The Altmetric Attention Score is recorded on the first business day of the month starting at least two months after publication. The business day is as determined in Melbourne, Australia.

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B